Experts in Intellectual Property & Business Law
Our Specialties
We combine technical excellence with business insight to deliver intelligent IP strategies that protect your ideas, reduce risk, and build enterprise value.
Startup Intellectual Property & Tax Strategy
We help startup companies build valuable patent portfolios with meaningful claim coverage while strategically structuring their businesses to maximize opportunities such as IRC §1202 Qualified Small Business Stock (QSBS) benefits.
LEARN MORE
Specialty Patent Work
Our patent practice is led by professionals who have firsthand experience bringing innovations from concept to patent protection. As the named inventor on more than 250 U.S. patents, our team understands the patent process from both the inventor’s and attorney’s perspective.
LEARN MORE
Intellectual Property for Young Innovators
We believe innovation begins with curiosity. From a student’s first creative spark in elementary school to the development of prototypes in high school, young inventors are discovering new ways to solve meaningful, real-world challenges.
LEARN MORE
About Kennedy Law Practice, P.C.
Kennedy Law Practice was founded by Thomas J. Kennedy III, a seasoned patent attorney, prolific inventor, and experienced legal advocate. With a rare combination of technical innovation and courtroom experience, Mr. Kennedy built the firm to serve inventors, businesses, and institutions seeking strategic, high-impact intellectual property protection.
Latest from The Blog
New In Vivo CAR-T Process : Focus On Delivery And Targeting
While in vitro therapies offer stable, long-term genetic integration and have paved the way for modern immuno-oncology, in vivo nanoparticle delivery represents a paradigm shift toward scalable, accessible, and rapid treatment modalities.
USPTO Reinstates Double Patenting Rejections In Ex Parte Baurin: What Life Sciences Innovators Need to Know
On August 6, 2026, the USPTO Appeals Review Panel (ARP) reinstated nonstatutory double patenting (NSDP) rejections against Sanofi’s application for antibody-like binding proteins. This precedential decision has significant implications for life sciences companies developing and improving upon innovative therapies.
Great IP is more than a patent. It’s a strategic asset that drives value, opens doors, and shapes the future.